Cynosure Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,220
Closed -$403K 457
2025
Q4
$403K Sell
1,220
-274
-18% -$92.9K 0.04% 363
2025
Q3
$516K Sell
1,494
-7,604
-84% -$2.3M 0.06% 171
2025
Q2
$2.84M Buy
9,098
+8,354
+1,123% +$3.19M 0.32% 38
2025
Q1
$390K Buy
744
+157
+27% +$80.3K 0.05% 164
2024
Q4
$297K Sell
587
-310
-35% -$176K 0.04% 259
2024
Q3
$525K Sell
897
-1,404
-61% -$794K 0.08% 148
2024
Q2
$1.17M Buy
2,301
+253
+12% +$124K 0.19% 69
2024
Q1
$1.01M Sell
2,048
-5,475
-73% -$2.78M 0.18% 63
2023
Q4
$3.96M Buy
7,523
+3,746
+99% +$2M 0.71% 31
2023
Q3
$1.9M Buy
3,777
+16
+0.4% +$7.87K 0.58% 46
2023
Q2
$1.81M Buy
+3,761
New +$1.84M 0.54% 47

Other funds holding UNH

Cynosure Group's UNH Position: Q1 2026 in Review

Cynosure Group sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 1,220 shares — an estimated $403K sold.

Cynosure Group first reported a position in UNH in Q2 2023 and held it in 11 quarters. The position peaked at $3.96M in Q4 2023. 3,021 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Cynosure Group reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
  • Cynosure Group sold 1,220 UnitedHealth shares in Q1 2026, an estimated $403K.
  • Cynosure Group first reported a position in UnitedHealth in Q2 2023 and held it in 11 quarters.
  • Cynosure Group's UnitedHealth position peaked at $3.96M in Q4 2023.
  • 3,021 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.